19h
Zacks Investment Research on MSNIs Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...
13h
Screen Rant on MSN"Dragon Ball Can't End": A Damning New Interview Reveals How Dragon Ball GT Really Came to LifeDragon Ball GT was the controversial follow-up to Dragon Ball Z, and a new interview unveils the real reason the sequel ...
H-E-B joins a lawsuit with Kroger, Albertsons and Walgreens to sue a pharmaceutical company for conspiring to delay the ...
Morgan Stanley upgraded Takeda (TAK) to Overweight from Equal Weight with a price target of 5,500 yen, up from 4,300 yen. The company does not ...
Benjamin Ping, the new general manager of Takeda Vietnam, talked to VIR’s Tung Anh about his leadership approach to foster ...
Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended Adcetris ...
“I am pleased to welcome Teresa to our Board of Directors,” said Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences. “She is a seasoned leader whose extensive operational and ...
Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...
Rio Takeda shot a blistering 8-under 64 to win the LPGA's Blue Bay tournament by six shots ahead of Minjee Lee.
The UK’s health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended brentuximab ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results